Viral and Cellular Factors Influencing HIV Tropism

  • Jay A. Levy
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 300)


Studies of the human immunodeficiency virus (HIV) have indicated that virus-infected cells are most likely the major source of infection, and any approach that kills only the virus would not control HIV infection (1). Early observations suggested that the CD4+ T helper lymphocyte was the major cell type infected by HIV (2). Subsequent studies have demonstrated that a wide variety of cells coming from the hematopoietic and central nervous systems, the skin and the bowel are susceptible to HIV (3). Based on observations on a variety of HIV isolates it appears likely that, depending on the particular virus strain infecting the host, any human cell could be infected by HIV (4) (Table1). Its detection might be difficult in some cells in which viral replication takes place at a low level. Nevertheless, the presence of HIV could be revealed by Southern blot or polymerase chain reaction(PCR) techniques. Most importantly, if tissues in the body are infected by HIV, even if producing low levels of the virus, their function may be compromised.


Human Immunodeficiency Virus Peripheral Blood Mononuclear Cell Human Immunodeficiency Virus Type Human Immunodeficiency Virus Infection Human Immunodeficiency Virus Replication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Levy, J.A. The tansmissison of AIDS: The case of the infected cell. J. Am. Med. Assoc. 259:3037 (1988).CrossRefGoogle Scholar
  2. 2.
    Klatzmann D., Barre-Sinoussi F., Nugeyre, M., et al. Selective tropism of lymphadenopathy-associated virus (LAV) for helper-inducer T lymphocytes. Science 225:59 (1984).PubMedCrossRefGoogle Scholar
  3. 3.
    Castro B., Cheng-Mayer, C., Evans, L.A., and Levy, J.A. HIV heterogeneity and viral pathogenesis. AIDS 2:l7 (1988).CrossRefGoogle Scholar
  4. 4.
    Levy, J.A. Changing concepts in HIV infection: Challenges for the 1990s. AIDS 4:1051 (1990).PubMedCrossRefGoogle Scholar
  5. 5.
    Kikkawa R., Yoyanagi Y., Harada, S., et al. Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell lines Molt-4. J. Virol. 57:1157 (1986).Google Scholar
  6. 6.
    Evans, L.A., McHugh T.M., Stites D.P., and Levy J.A. Differential ability of human immunodeficiency virus isolates to productively infect human cells. J. Immunol. 138:3415 (1987).PubMedGoogle Scholar
  7. 7.
    Maddon P.J., Dalgleish A.G. McDougal J.A., et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333 (1986).PubMedCrossRefGoogle Scholar
  8. 8.
    Levy J.A., Human immunodeficiency viruses and the pathogenesis of AIDS. J. Am. Med. Assoc. 261:2997 (1989).CrossRefGoogle Scholar
  9. 9.
    Gallaher W.R. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 50:327 (1987).PubMedCrossRefGoogle Scholar
  10. 10.
    Merz D.C., Scheid, A. and Choppin, P.W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J. Exp. Med. 151:275 (1980).PubMedCrossRefGoogle Scholar
  11. 11.
    Cheng-Mayer C., Rutka J.T., Rosenblum M.L., McHugh T., Stites D.P, and Levy J.A. The human immunodeficiency virus (HIV) can productively infect cultured human glial cells. Proc. Proc. Natl. Acad. Sci. 84:3526 (1987).CrossRefGoogle Scholar
  12. 12.
    Chiodi, F., Fuerstenberg, S., Gidlund, M., Asjo, B., and Fenyo, E.M. Infection of brain-derived cells with the human immunodeficiency virus. J. Virol. 61:1244 (1987).PubMedGoogle Scholar
  13. 13.
    Dewhurst, S., Sakai, K., Bresser, J., Stevenson, M., Evinger-Hodges, M.J. and Volsky, D.J. Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J. Virol. 61:3774 (1987).PubMedGoogle Scholar
  14. 14.
    Clapham, P., Weber, J.N., Whitby, D., McKintosh, K., Dalgleish, A.G., Maddon, P.J., Deen, K.C., Sweet, R.W. and Weiss, R.A. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature 337:368 (1989).PubMedCrossRefGoogle Scholar
  15. 15.
    Harouse J.M., Kunsch C., Hartle H.T. et al. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63:2527 (1989).PubMedGoogle Scholar
  16. 16.
    Tateno M., Gonzalez-Scarano F., and Levy, J.A. The human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc. Natl. Acad. Sci. 86:4287, 1989.PubMedCrossRefGoogle Scholar
  17. 17.
    Cao Y.Z., Friedman-Kien A.E., Huang Y.X., et al. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J. Virol. 64:2553 (1990).PubMedGoogle Scholar
  18. 18.
    Nelson J.A., Wiley CA., Reynolds-Kohler C., Reese C.E., Margaretten W., and Levy, J.A. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1:259 (1988).PubMedCrossRefGoogle Scholar
  19. 19.
    Cohen A.H., Sun N.C.J., Shapshak P., and Imagawa D.T. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod. Pathol. 2:125 (1989).PubMedGoogle Scholar
  20. 20.
    Nabel G., and Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711 (1987).PubMedCrossRefGoogle Scholar
  21. 21.
    Osborn L., Kunkel S., and Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc. Natl. Acad. Sci. 86:2336 (1989).PubMedCrossRefGoogle Scholar
  22. 22.
    Schwartz S., Felber B.K. Fenyo E.-M, and Pavlakis G.N. Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines. Proc. Natl. Acad. Sci. 86:7200 (1989).PubMedCrossRefGoogle Scholar
  23. 23.
    Koenig, S., Gendelman, H.E., Orenstein, J.M., Dal Canto, M.C. et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089 (1986).PubMedCrossRefGoogle Scholar
  24. 24.
    Wiley, C.A., Schrier R.D., Nelson J.A., Lampert P.W., and Oldstone M.B.A. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. 83:7089 (1986).PubMedCrossRefGoogle Scholar
  25. 25.
    Leonard H., Calabrese D.O. Proffitt M.R., et al. Congestive cardiomyopathy and illness related to the acquired immunodeficiency syndrome (AIDS) associated with isolation of retrovirus from myocardium. Ann. Intern. Med. 107:691 (1987).Google Scholar
  26. 26.
    Plata F., Garcia-Pons F., Ryier A., et al. HIV-1 infection of lung alveolar fibroblasts and macrophages in humans. AIDS Res. Hum. Retroviruses 6:979 (1990).PubMedGoogle Scholar
  27. 27.
    Adachi, A., Koenig, S., Gendelman, H.E., Daugherty, D., Gattoni-Celli, S., Fauci, A.S. and Martin, M.A. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J. Virol. 61:209 (1987).PubMedGoogle Scholar
  28. 28.
    Levy J.A., Evans L.A., Cheng-Mayer C., et al. The biologic and molecular properties of the AIDS-associated retrovirus that affect antiviral therpay. Ann. Inst. Pasteur 138:101 (1987).CrossRefGoogle Scholar
  29. 29.
    Cheng-Mayer C., Weiss C., Seto D., and Levy J.A. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc. Natl. Acad. Sci. 80:8575 (1989).CrossRefGoogle Scholar
  30. 30.
    Barnett S., Barboza A.J., Wilcox C.M., Forsmark CE., and Levy J.A. Characterization of HIV-1 strains recovered from the bowel. 6th International Conference on AIDS. San Francisco, June 1990 [abstract S.A. 68].Google Scholar
  31. 31.
    Cheng-Mayer C., Seto D., and Levy J.A. Altered host range of HIV-1 after passage through different human cell types. Virology, in press.Google Scholar
  32. 32.
    York-Higgins D, Cheng-Mayer C., Bauer D, Levy J.A., and Dina D. Human immunodeficiency virus type 1 cellular host range, replication and cytopathicity are linked to the envelope region of the viral genome. J. Virol. 64:4016 (1990).PubMedGoogle Scholar
  33. 33.
    Cheng-Mayer C., Quiroga M., Tung, J.W., Dina D.,and Levy J.A. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J. Virol. 64:4390 (1990).PubMedGoogle Scholar
  34. 34.
    Shioda, T., Levy, J.A. and Cheng-Mayer, C. Macrophage and T cell line tropisms of HIV-1 are determined by specific regions of the envelope gpl20. Nature (in press).Google Scholar
  35. 35.
    LaRosa G.J., Davide J.P, Weinhold K., et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249:932 (1990).PubMedCrossRefGoogle Scholar
  36. 36.
    Homsy J., Tateno M., and Levy, J.A. Antibody-dependent enhancement of HIV infection. Lancet 1:1285 (1988).Google Scholar
  37. 37.
    Homsy J., Meyer M., Tateno M, Clarkson S., and Levy J.A. The Fc and not the CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244:1357 (1989).PubMedCrossRefGoogle Scholar
  38. 38.
    Takeda, A. and Ennis, F.A. FcR-mediated enhancement of HIV-1 infection by antibody AIDS Research and Human Retroviruses 6:999 (1990).PubMedGoogle Scholar
  39. 39.
    Robinson W.E., Montefiori D.C., and Mitchell W.M. Antibody dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1:790 (1988).PubMedCrossRefGoogle Scholar
  40. 40.
    Robinson, W.E., Jr., Kawamura, T., Lake, D., Masuho, Y., Mitchell, W.M. and Hersh, E.M. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro. J. Virol. J. Virol 64(11):5301 (1990).PubMedGoogle Scholar
  41. 41.
    Robinson, W.E., Jr., Montefiori, D.C. and Mitchell W.M. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 175:600 (1990).PubMedCrossRefGoogle Scholar
  42. 42.
    Halstead S.B., and O’Rourke E.J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146:210 (1977).Google Scholar
  43. 43.
    McKeating J.A., Griffiths P.D., and Weiss R.A. HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature 343:659 (1990).PubMedCrossRefGoogle Scholar
  44. 44.
    Homsy J., Meyer M., and Levy J.A. Serum enhancement of human immunodeficiency virus (HIV) correlates with disease in HIV-infected individuals. J. Virol. 64:1437 (1990).PubMedGoogle Scholar
  45. 45.
    Hoxie J.A., Haggarty B.S., Rackowski J.L., Pilsbury N., and Levy J.A. Persistent noncytopathic infection of human lymphocytes with AIDS-associated retrovirus (ARV). Science 229:1400 (1985).PubMedCrossRefGoogle Scholar
  46. 46.
    Folks T., Powell D.M., Lightfoote M.M., et al. Induction of HTLV-III/LAV from a non virus-producing T cell line: Implications for latency. Science 231:600 (1986).PubMedCrossRefGoogle Scholar
  47. 47.
    Luciw P.A., Cheng-Mayer C., and Levy J.A. Mutational analysis of the human immunodeficiency virus (HIV): The orf-B region down-regulates virus replication. Proc. Natl. Acad. Sci. 84:1434 (1987).PubMedCrossRefGoogle Scholar
  48. 48.
    Cheng-Mayer C., Ianello P., Shaw K, Luciw P., and Levy J.A. Differential effects of nef on HIV replication: Implications for viral pathogenesis in the host. Science 246:1629 (1989).PubMedCrossRefGoogle Scholar
  49. 49.
    Kim S., Ikeuchi K., Byrn R., Groopman J., and Baltimore D. Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc. Natl. Acad.Sci. 86:9549 (1989).CrossRefGoogle Scholar
  50. 50.
    Hammes S.R., Dixon E.P., Maum M.H. Cullen B.R., and Greene W.C. Nef protein of human immunodeficiency virus typ 1: Evidence against its role as a transcriptional inhibitor. Proc. Natl. Acad Sci. 86:9549 (1989)PubMedCrossRefGoogle Scholar
  51. 51.
    Guy B., Kieny M.P., Riviere Y., Le Peuch C., Dott K., Girard M., Montagnier L. and Lecoco J.P. HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330:266 (1987).PubMedCrossRefGoogle Scholar
  52. 52.
    Poulin L. and Levy, J.A.In vitro expression of a functional HIV-nef gene product.V International Congress on AIDS,Montreal, 1989, p 58.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Jay A. Levy
    • 1
  1. 1.Department of Medicine and Cancer Research InstituteUniversity of California, School of MedicineSan FranciscoUSA

Personalised recommendations